A case of Severe Low-dose Methotrexate-induced Toxicity
Methotrexate (MTX) is an antimetabolite which competitively inhibits dihydrofolic acid reductase; inhibits purine and thymidylic acid synthesis, which in turn interferes with DNA synthesis, repair, and cellular replication. MTX is a good treatment option for neoplastic, rheumatic and dermatological...
Main Authors: | Filiz Topaloğlu Demir, Yavuz Tezcan, Zafer Türkoğlu, Şerife Başaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2016-12-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: | http://www.hasekidergisi.com/article_13413/A-Case-Of-Severe-Low-dose-Methotrexate-induced-Toxicity |
Similar Items
-
Acute methotrexate toxicity due to overdosing in psoriasis: A series of seven cases
by: Swetalina Pradhan, et al.
Published: (2019-01-01) -
Methotrexate-induced cutaneous ulceration in 3 nonpsoriatic patients: Report of a rare side effect
by: Hal A. Lewis, BS, et al.
Published: (2017-05-01) -
Oral events related to low-dose methotrexate in rheumatoid arthritis patients
by: Carlos Henrique Silva Pedrazas, et al.
Published: (2010-09-01) -
Uncommon toxicity of low-dose methotrexate: case report
by: Zohreh Yousefi, et al.
Published: (2015-10-01) -
Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
by: Ning Xin, et al.
Published: (2019-09-01)